MedBioSphere
Articles Videos The Web  
    

Sheffield Medical Technologies

Selected Abstract

Sheffield Medical Technologies Investigator Publishes on Clotrimazole
NEW YORK, Nov. 15 /PRNewswire/ -- Sheffield Medical Technologies Inc. (AMEX: SHM) and its wholly owned subsidiary Ion Pharmaceuticals, Inc. announced today that its collaborators at Children's Hospital in Boston have recently published studies in The Journal of Clinical Investigation, which ...
November 15, 1996; PR Newswire

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. SHEFFIELD MEDICAL TECHNOLOGIES REPORTS FIRST QUARTER FINANCIAL RESULTS
2. Sheffield Medical Technologies Reports Second Quarter Financial Results
3. edical Technologies Reports First Quarter Financial Results
4. SHEFFIELD MEDICAL TECHNOLOGIES INC. REPORTS 1995 THIRD QUARTER RESULTS
5. SHEFFIELD MEDICAL TECHNOLOGIES REPORTS FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS
6. Sheffield Medical Technologies Reports Financial Results and Highlights Third Quarter Progress
7. SHEFFIELD MEDICAL TECHNOLOGIES AND SEQUUS PHARMACEUTICALS SIGN OPTION AGREEMENT FOR LICENSE TO DEVELOP AND COMMERCIALIZE NEW HIV/AIDS THERAPEUTIC
8. Sheffield Medical Technologies Completes Private Placement
9. Sheffield Medical Technologies Names Thomas M. Fitzgerald President
10. SHEFFIELD MEDICAL TECHNOLOGIES FORMS SUBSIDIARY TO ADVANCE ANTI- PROLIFERATIVE DRUG PROGRAM